Allergy Section, Hospital Marina Baixa, Villajoyosa and Centro de Especialidades Foietes, Benidorm, Spain.
Int Arch Allergy Immunol. 2013;162(2):115-22. doi: 10.1159/000351068. Epub 2013 Jul 31.
Although allergy to Cannabis sativa was first reported over 40 years ago, the allergenicity has scarcely been studied. The objectives of this study were to investigate the frequency of sensitization to this plant, to analyze the clinical characteristics and allergenic profile of sensitized individuals and to identify the allergens involved.
Five hundred and forty-five individuals in Spain attending allergy clinics with respiratory or cutaneous symptoms underwent a skin-prick test (SPT) with C. sativa leaf extract. The extract was characterized by SDS-PAGE and 2-dimensional electrophoresis. Specific IgE to C. sativa was measured in positive SPT individuals. The clinical and allergenic profiles of sensitized individuals were investigated and the most-recognized allergens sequenced and characterized by liquid chromatography-mass spectrometry/mass spectrometry.
Of this preselected population, 44 individuals had positive SPT to C. sativa (prevalence 8.1%). Prevalence was higher in individuals who were C. sativa smokers (14.6%). Two individuals reported mild symptoms with C. sativa. Twenty-one individuals from 32 available sera (65.6%) had positive specific IgE to C. sativa. Twelve sera recognized at least 6 different bands in a molecular-weight range of between 10 and 60 kDa. Six of them recognized a 10-kDa band, identified as a lipid transfer protein (LTP) and 8 recognized a 38-kDa band, identified as a thaumatin-like protein.
There is a high prevalence of sensitization to C. sativa leaves. The clinical symptoms directly attributed to C. sativa were uncommon and mild. The sensitization profile observed suggests that C. sativa sensitization may be mediated by two mechanisms, i.e. cross-reactivity, mainly with LTP and thaumatin-like protein, and exposure-related 'de novo' sensitization.
尽管对大麻过敏早在 40 多年前就有报道,但对其变应原性的研究甚少。本研究旨在调查对该植物致敏的频率,分析致敏个体的临床特征和变应原谱,并确定涉及的变应原。
在西班牙,545 名因呼吸道或皮肤症状而到过敏诊所就诊的个体接受了大麻叶提取物的皮肤点刺试验(SPT)。提取物通过 SDS-PAGE 和 2 维电泳进行了特征分析。在 SPT 阳性个体中测量了对大麻的特异性 IgE。调查了致敏个体的临床和变应原谱,并对最具代表性的变应原进行测序,并通过液相色谱-质谱/质谱进行了特征分析。
在这一预选人群中,44 名个体对大麻的 SPT 呈阳性(患病率为 8.1%)。大麻吸烟者的患病率更高(14.6%)。有 2 名个体报告了与大麻接触后的轻度症状。在 32 份可获得的血清中,有 21 份(65.6%)对大麻有阳性特异性 IgE。12 份血清在 10 至 60 kDa 的分子量范围内识别出至少 6 种不同的条带。其中 6 份血清识别出一种 10 kDa 的条带,鉴定为脂质转移蛋白(LTP),8 份血清识别出一种 38 kDa 的条带,鉴定为类甜蛋白。
对大麻叶的致敏率很高。直接归因于大麻的临床症状不常见且较轻。观察到的致敏谱表明,大麻致敏可能通过两种机制介导,即交叉反应,主要与 LTP 和类甜蛋白有关,以及与暴露相关的“新”致敏。